To play this video you need to enable JavaScript in your browser.This video can not be played
ClosePatients in England with a specific type of incurable breast cancer can now access a life-extending drug on the NHS.
Enhertu can give patients almost seven extra months to live on average.
Women in Scotland have had access to the drug on the NHS since 2023, and it is available in 26 other European countries.
Doctors in England are now able to prescribe it, with Wales expected to follow shortly but the guidance doesn't automatically apply to Northern Ireland.
Kate Wills, 51, has HER2-low metastatic breast cancer, which has spread to her bones and lungs.
When she hears it will be available on the NHS, she immediately starts crying. "I really can't believe it. I'm so relieved, I'm overjoyed," she says.
"It's so hard keeping hope when you have stage four cancer. This gives me enormous hope."
SubsectionHealthPublished16 minutes agoShareclose panelShare pageCopy linkAbout sharingRelated topicsDrug breakthroughsFollow Drug breakthroughs
close panelYou are now following Drug breakthroughsUpdates from your News topics will appear in My News and in a collection on the News homepage.CancerFollow Cancer
close panelYou are now following CancerUpdates from your News topics will appear in My News and in a collection on the News homepage.NHSFollow NHS
close panelYou are now following NHSUpdates from your News topics will appear in My News and in a collection on the News homepage.Breast cancerFollow Breast cancer
close panelYou are now following Breast cancerUpdates from your News topics will appear in My News and in a collection on the News homepage.NHS EnglandFollow NHS England
